JP2022519154A5 - - Google Patents
Info
- Publication number
- JP2022519154A5 JP2022519154A5 JP2021532325A JP2021532325A JP2022519154A5 JP 2022519154 A5 JP2022519154 A5 JP 2022519154A5 JP 2021532325 A JP2021532325 A JP 2021532325A JP 2021532325 A JP2021532325 A JP 2021532325A JP 2022519154 A5 JP2022519154 A5 JP 2022519154A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- population
- cells
- items
- immune cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024165533A JP2025000745A (ja) | 2018-12-07 | 2024-09-24 | 免疫療法のための組成物および方法 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811501797.8 | 2018-12-07 | ||
| CN201811501797 | 2018-12-07 | ||
| CNPCT/CN2019/073252 | 2019-01-25 | ||
| CN2019073252 | 2019-01-25 | ||
| CN201910297171.8 | 2019-04-12 | ||
| CN201910297171 | 2019-04-12 | ||
| CN2019097996 | 2019-07-26 | ||
| CNPCT/CN2019/097996 | 2019-07-26 | ||
| PCT/CN2019/123684 WO2020114491A1 (en) | 2018-12-07 | 2019-12-06 | Compositions and methods for immunotherapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024165533A Division JP2025000745A (ja) | 2018-12-07 | 2024-09-24 | 免疫療法のための組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022519154A JP2022519154A (ja) | 2022-03-22 |
| JP2022519154A5 true JP2022519154A5 (cg-RX-API-DMAC7.html) | 2022-12-14 |
Family
ID=70974083
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021532325A Pending JP2022519154A (ja) | 2018-12-07 | 2019-12-06 | 免疫療法のための組成物および方法 |
| JP2024165533A Pending JP2025000745A (ja) | 2018-12-07 | 2024-09-24 | 免疫療法のための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024165533A Pending JP2025000745A (ja) | 2018-12-07 | 2024-09-24 | 免疫療法のための組成物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20210369779A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3891272A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2022519154A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210125986A (cg-RX-API-DMAC7.html) |
| CN (2) | CN118931967A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019393243A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL283644A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202106053SA (cg-RX-API-DMAC7.html) |
| TW (1) | TW202100747A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020114491A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201700621D0 (en) | 2017-01-13 | 2017-03-01 | Guest Ryan Dominic | Method,device and kit for the aseptic isolation,enrichment and stabilsation of cells from mammalian solid tissue |
| SI3844267T1 (sl) | 2018-08-31 | 2025-10-30 | Novartis Ag | Postopki izdelave celic, ki izražajo receptorje himernega antigena |
| EP4578507A3 (en) | 2018-11-01 | 2025-11-12 | Gracell Biotechnologies (Shanghai) Co., Ltd. | Compositions and methods for t cell engineering |
| JP2023507432A (ja) | 2019-12-20 | 2023-02-22 | インスティル バイオ (ユーケイ) リミテッド | 腫瘍浸潤リンパ球を単離するためのデバイスおよび方法ならびにそれらの使用 |
| WO2022130016A1 (en) * | 2020-12-18 | 2022-06-23 | Instil Bio (Uk) Limited | Tumor infiltrating lymphocytes and anti-cd47 therapeutics |
| CN117594124A (zh) * | 2021-06-15 | 2024-02-23 | 南京医科大学 | 一种基于单核细胞预测胶质瘤的试剂盒、系统和应用 |
| WO2023278553A1 (en) * | 2021-07-01 | 2023-01-05 | Kite Pharma, Inc. | Closed-system and method for autologous and allogeneic cell therapy manufacturing |
| WO2024013702A2 (en) * | 2022-07-15 | 2024-01-18 | Medimmune, Llc | Methods for expanding t cell populations |
| TWI837927B (zh) * | 2022-11-03 | 2024-04-01 | 沛爾生技醫藥股份有限公司 | 生產富含幹細胞樣記憶t細胞之人類嵌合抗原受體t細胞的方法 |
| CN117924518B (zh) * | 2024-01-05 | 2025-08-22 | 苏州艾凯利元生物科技有限公司 | 用于nk细胞的嵌合抗原受体及工程化的nk细胞 |
| WO2025213573A1 (zh) * | 2024-04-12 | 2025-10-16 | 恺兴生命科技(上海)有限公司 | 细胞免疫疗法的组合物和方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070036773A1 (en) * | 2005-08-09 | 2007-02-15 | City Of Hope | Generation and application of universal T cells for B-ALL |
| PH12013501201A1 (en) * | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| KR102229108B1 (ko) * | 2011-05-03 | 2021-03-18 | 이뮤노베이티브 테라피스, 엘티디. | 생세포를 포함하는 생물학적 약물을 처리하기 위한 방법 |
| WO2014055442A2 (en) * | 2012-10-01 | 2014-04-10 | The Trustees Of The University Of Pennsylvania | Compositions and methods for targeting stromal cells for the treatment of cancer |
| AU2013204922B2 (en) * | 2012-12-20 | 2015-05-14 | Celgene Corporation | Chimeric antigen receptors |
| WO2014138348A1 (en) * | 2013-03-06 | 2014-09-12 | The Trustees Of The University Of Pennsylvania | Iikaros inhibition to augment adoptive t cell transfer |
| KR20240164967A (ko) * | 2014-02-04 | 2024-11-21 | 카이트 파마 인코포레이티드 | B 세포 악성종양 및 다른 암을 치료하는데 유용한 자가 t 세포 및 그의 조성물의 생산 방법 |
| JP6740234B2 (ja) * | 2014-11-05 | 2020-08-12 | ジュノー セラピューティクス インコーポレイテッド | 形質導入および細胞プロセシングのための方法 |
| WO2017070042A1 (en) * | 2015-10-20 | 2017-04-27 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of producing t cell populations using akt inhibitors |
| CN108017717B (zh) * | 2018-01-24 | 2019-08-16 | 首都医科大学宣武医院 | 一种用于体外高效定向扩增的嵌合抗原受体及其应用 |
| MX2021002702A (es) * | 2018-09-10 | 2021-05-12 | Atara Biotherapeutics Inc | Metodos para expandir celulas t del receptor de antigeno quimerico especificas de antigenos, composiciones y usos relacionados con las mismas. |
| CN110358734B (zh) * | 2019-06-13 | 2020-08-25 | 首都医科大学宣武医院 | 以Tcm为主要效应成分的CAR-T制备方法及其应用 |
-
2019
- 2019-12-06 CN CN202410984775.0A patent/CN118931967A/zh active Pending
- 2019-12-06 CN CN201980091527.0A patent/CN113574172A/zh active Pending
- 2019-12-06 JP JP2021532325A patent/JP2022519154A/ja active Pending
- 2019-12-06 WO PCT/CN2019/123684 patent/WO2020114491A1/en not_active Ceased
- 2019-12-06 EP EP19893371.5A patent/EP3891272A4/en active Pending
- 2019-12-06 AU AU2019393243A patent/AU2019393243A1/en not_active Abandoned
- 2019-12-06 TW TW108144827A patent/TW202100747A/zh unknown
- 2019-12-06 SG SG11202106053SA patent/SG11202106053SA/en unknown
- 2019-12-06 KR KR1020217021252A patent/KR20210125986A/ko active Pending
-
2021
- 2021-06-02 IL IL283644A patent/IL283644A/en unknown
- 2021-06-04 US US17/338,972 patent/US20210369779A1/en not_active Abandoned
-
2024
- 2024-06-17 US US18/745,930 patent/US20240335474A1/en active Pending
- 2024-09-24 JP JP2024165533A patent/JP2025000745A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vivier et al. | Natural killer cell therapies | |
| Manier et al. | Current state and next-generation CAR-T cells in multiple myeloma | |
| Gargett et al. | Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2 | |
| Daher et al. | CAR‐NK cells: the next wave of cellular therapy for cancer | |
| US10918667B2 (en) | Modified cell expressing therapeutic agent and uses thereof | |
| JP6563554B2 (ja) | Carの抗腫瘍活性のための毒性管理 | |
| Priceman et al. | Smart CARs engineered for cancer immunotherapy | |
| Jensen et al. | Designing chimeric antigen receptors to effectively and safely target tumors | |
| Cappuzzello et al. | Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells | |
| JP2021058196A5 (cg-RX-API-DMAC7.html) | ||
| Kwon et al. | Molecular checkpoints controlling natural killer cell activation and their modulation for cancer immunotherapy | |
| JP2017522893A (ja) | Ror1特異的多重鎖キメラ抗原受容体 | |
| AU2016349724A1 (en) | Chimeric receptors containing TRAF-inducing domains and related compositions and methods | |
| CN117802051A (zh) | 修饰的细胞及组合物 | |
| JP2021505615A5 (cg-RX-API-DMAC7.html) | ||
| Kiaei et al. | Advances in natural killer cell therapies for breast cancer | |
| CN110257338B (zh) | 嵌合细胞因子受体 | |
| CN109908176A (zh) | 免疫效应细胞和辐射联用在治疗肿瘤中的用途 | |
| Sukari et al. | Unleash the power of the mighty T cells-basis of adoptive cellular therapy | |
| KR20220144888A (ko) | 최적화된 다기능 t 세포를 포함하는 키메라 수용체 t 세포를 사용하는 치료 | |
| US20230227576A1 (en) | Receptors providing targeted costimulation for adoptive cell therapy | |
| KR20220012224A (ko) | 입양 전달 요법에서 t 림프구 및 nk 세포의 확장 및 분화를 위한 방법 | |
| Marple et al. | Improving CAR T-cells: The next generation | |
| CN112680419A (zh) | 嵌合抗原受体细胞分泌治疗剂 | |
| Hu et al. | Application of adoptive cell therapy in malignant melanoma |